Observation period (years)* | 22, 2–35 | 3.5, 2.0–4.5 |
Repeated surgery | | |
None | 1 | 3 |
Once | 4 | 0 |
Twice or more | 4 | 0 |
Medication for intestinal pathology | | |
No | 1 | 3 |
Yes | 8 | 0 |
Iron supplementation | 7 | |
Enteral or parenteral nutrition | 5 | |
Mesalazine | 1 | |
Extraintestinal manifestations | | |
None | 6 | 2 |
Autoimmune disorder | 0 | 0 |
Haematological disorder | 0 | 1 |
Vascular disorder | 0 | 0 |
Final clinical parameters* | (n = 7) | (n = 3) |
Haemoglobin (g/l) | 111, 59–139 | 116, 93–161 |
Serum protein (g/l) | 63, 51–74 | 67, 58–78 |
C reactive protein (g/l) | 2, 1–4 | 0, 0–2 |
Clinical outcome | | |
Alive | 8 | 6 |
Deceased | 1 | 0 |